Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK’s Bexsero, Shingrix to pass $1B sales mark by 2022: report
GSK’s Bexsero, Shingrix to pass $1B sales mark by 2022: report
GSK’s Bexsero, Shingrix to pass $1B sales mark by 2022: report
Submitted by
admin
on June 21, 2017 - 11:01am
Source:
Fierce Pharma
News Tags:
GSK
Bexsero
Shingrix
vaccines
shingles
meningitis B
Headline:
GSK’s Bexsero, Shingrix to pass $1B sales mark by 2022: report
Do Not Allow Advertisers to Use My Personal information
